Skip to main content
TipRanks
Go Ultimate75% OFF

a2 Milk Company (ATM) AI Stock Analysis

1 Followers
NZ:ATM

a2 Milk Company

(NZX:ATM)

Select Model
Rating:69Neutral
Price Target:NZD 10.00â–²(27.88% Upside)
Action:initiatedcoverage
Date:10/05/26

The score is supported primarily by strong profitability and an exceptionally conservative balance sheet, plus a high dividend yield. Offsetting these positives are weakened recent cash flow/cash conversion, and earnings-call guidance indicating near-term margin pressure and a second-half-weighted recovery following supply-chain disruption impacts. Technical signals are neutral, offering limited confirmation of momentum.

Positive Factors
Strong profitabilityThe company has built a comparatively strong profitability profile, with gross and net margins materially improved from earlier years and operating margins remaining healthy. This provides internal funding capacity for marketing, innovation, and supply-chain investment while supporting resilience through category or geographic volatility.
Negative Factors
China IMF disruption and share lossThe disruption caused significant product unavailability and prompted many existing users to switch brands, making recovery dependent on winning back prior customers and recruiting new ones. Persistent share erosion in China label infant formula could weigh on revenue, mix, and brand economics.

a2 Milk Company (ATM) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%NZ:ATM-22.93%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
NZD 3.51B
Dividend Yield
7.97%
Average Volume (3M)
290.25K
Price to Earnings (P/E)
25.3
Beta (1Y)
0.90
Revenue Growth
3.84%
EPS Growth
6.53%
Country
NZ
Employees
485
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

a2 Milk Company Business Overview & Revenue Model

Company Description

Headquartered in Auckland, New Zealand, The a2 Milk Company Limited was founded in 2000. Operating with its subsidiaries, the company specializes in marketing and distributing branded milk and related products that contain the A2 protein type. These...

How the Company Makes Money

The a2 Milk Company makes money primarily by selling branded dairy and nutrition products, with revenue generated from the wholesale and retail sale of A2 protein-only products. Its main revenue streams include (1) infant formula and related nutritio...

a2 Milk Company Earnings Call Summary

Earnings Call Date:Aug 16, 2026(Q4-2026)|Next Earnings Date:Feb 22, 2027
Earnings Call SentimentNeutral

The call presented a mixed picture: the company delivered strong top-line growth (+12.4%), solid underlying EBITDA and multiple growth vectors (U.S., ANZ, other nutritionals, innovation), completed strategic supply-chain moves (a2 Pokeno) and returned significant capital to shareholders. However, a material fourth-quarter supply-chain disruption severely impacted China label IMF sales and in-market availability, pressured reported margins and required elevated marketing and recovery spend. Management outlined a clear recovery plan and expects FY'27 growth weighted to the second half, but near-term margin and sales phasing remain challenged.

Positive Updates

Revenue Growth
Group revenue increased 12.4% year-on-year to approximately $1.97 billion (FY'26), driven by broad-based growth across geographies and product categories.

Negative Updates

Material Supply Chain Disruption Impacting China IMF
Fourth-quarter supply chain disruption materially impacted China label IMF product availability, leading to a significant hit to in-market availability, higher supply-chain costs and second-half sales and earnings; causes included freight issues, Synlait production backlog, extended release times and additional customs/testing requirements.

Company Guidance

The company guided FY27 to mid‑single‑digit revenue growth with first‑half revenue broadly in line with FY26 and group revenue and EBITDA materially weighted to the second half; it expects EBITDA margin of approximately 15% (versus FY25 EBITDA margin of 16.6% and FY26 underlying margin of 15.6%), with most of the ~1.6 percentage‑point year‑on‑year decline driven by gross‑margin headwinds (mix dilution as IMF is broadly flat while liquid milk and other nutritionals grow, plus higher milk/ingredient COGS) and a higher marketing reinvestment profile (phased into H1, roughly ~2 percentage points higher reinvestment in H1), IMF sales to be impacted by Q4 supply‑chain flow‑on effects with a gradual recovery over the year supported by increased marketing, and a2 Pokeno expected to reach EBITDA breakeven in FY27.

a2 Milk Company Financial Statement Overview

Summary

Profitability and financial resilience are strong (gross margin ~47.7% and net margin ~11% in 2026; very low leverage with debt-to-equity ~0.02 and strong ~20% ROE). However, quality weakened in the latest year due to a sharp drop in cash generation (free cash flow down ~71% YoY; weaker cash conversion vs earnings) and a small revenue decline in 2026, which reduces confidence in near-term durability.

Income Statement

78Positive

Balance Sheet

86Very Positive

Cash Flow

52Neutral
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.97B1.97B1.90B1.67B1.59B1.44B
Gross Profit940.38M940.38M875.15M766.63M739.16M663.52M
EBITDA304.05M304.05M318.06M273.34M219.42M196.34M
Net Income216.70M216.70M202.89M167.58M155.64M122.62M
Balance Sheet
Total Assets1.96B1.96B1.94B1.73B1.61B1.72B
Cash, Cash Equivalents and Short-Term Investments784.47M784.47M1.10B968.94M802.23M887.31M
Total Debt24.31M24.31M100.74M66.22M101.53M124.35M
Total Liabilities887.99M887.99M511.37M478.10M462.21M521.89M
Stockholders Equity1.07B1.07B1.45B1.27B1.15B1.18B
Cash Flow
Free Cash Flow59.67M59.67M197.51M235.22M101.21M198.86M
Operating Cash Flow133.14M133.14M201.48M255.74M111.28M203.80M
Investing Cash Flow148.84M148.84M-92.28M-37.14M-13.94M-669.99M
Financing Cash Flow-211.51M-211.51M-28.27M-49.81M-178.43M9.64M

a2 Milk Company Technical Analysis

Technical Analysis SentimentNegative
Last Price7.82

Price Trends

50DMA8.45Negative
100DMA8.36Negative
200DMA8.57Negative

Market Momentum

MACD-0.00Positive
RSI31.30Neutral
STOCH19.64Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:ATM, the sentiment is Negative. The current price of 7.82 is below the 20-day moving average (MA) of 8.69, below the 50-day MA of 8.45, and below the 200-day MA of 8.57, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 31.30 is Neutral, neither overbought nor oversold. The STOCH value of 19.64 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:ATM.

a2 Milk Company Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

NZ:ATM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NZ:LICNZ:LIC80OutperformNZD 163.46M7.55―10.66%6.67%-30.47%
NZ:SCLNZ:SCL69NeutralNZD 948.37M10.86―4.32%100.12%60.22%
NZ:ATMNZ:ATM69NeutralNZD 5.83B25.2717.63%7.97%3.84%6.53%
NZ:CVTNZ:CVT68NeutralNZD 98.69M7.619.98%―10.67%―
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
NZ:TGGNZ:TGG52NeutralNZD 286.75M21.99――-17.18%196.29%
NZ:SMLNZ:SML49NeutralNZD 319.69M-4.12-10.58%―-7.94%-95.77%

* Consumer Defensive Sector Average

Performance Comparison

-25%0%25%50%NZ:ATMNZ:CVTNZ:SMLNZ:LICNZ:SCLNZ:TGGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
NZ:ATM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NZ:ATMa2 Milk Company Ltd.7.82-2.20-21.99%
NZ:CVTComvita 0.760.2651.09%
NZ:SMLSynlait Milk Ltd.0.50-0.20-28.57%
NZ:LICLivestock Improvement Corporation Ltd1.150.2224.19%
NZ:SCLScales Corp. Ltd.6.300.529.00%
NZ:TGGT&G Global Limited2.280.052.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 05, 2026